Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radha Rajasingham
David R Boulware

Showing results (1-10 of 435) with videos related to

Pageof 44
Sort By:
Lancet (London, England)|March 14, 2015
HIV care: ART adherence support and cryptococcal screeningRadha Rajasingham, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2019
Cryptococcal Antigen Screening and Preemptive Treatment-How Can We Improve Survival?Radha Rajasingham, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2019
New US Food and Drug Administration Approvals Decrease Generic Flucytosine CostsRadha Rajasingham, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2012
Reconsidering cryptococcal antigen screening in the U.S. among persons with CD4 <100 cells/mcLRadha Rajasingham, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2020
Reply to NevesMelanie R Nicol, David R Boulware, Radha Rajasingham
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2012
Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV careRadha Rajasingham, David B Meya, David R Boulware
JAMA Network Open|January 21, 2026
Is It Time to Use Single-Dose Amphotericin B for HIV-Related Cryptococcal Meningitis?Nathan C Bahr, Radha Rajasingham, David R Boulware
Medicine|August 5, 2018
A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in UgandaSarah M Lofgren, Elizabeth Nalintya, David B Meya, et al.
Plos Medicine|October 12, 2012
Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysisRadha Rajasingham, Melissa A Rolfes, Kate E Birkenkamp, et al.
Emerging Infectious Diseases|March 25, 2014
Nosocomial drug-resistant bacteremia in 2 cohorts with cryptococcal meningitis, AfricaRadha Rajasingham, Darlisha Williams, David B Meya, et al.
Pageof 44

Showing results (1-10 of 435) with videos related to

Sort By:
Pageof 44
Lancet (London, England)|March 14, 2015
HIV care: ART adherence support and cryptococcal screeningRadha Rajasingham, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2019
Cryptococcal Antigen Screening and Preemptive Treatment-How Can We Improve Survival?Radha Rajasingham, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2019
New US Food and Drug Administration Approvals Decrease Generic Flucytosine CostsRadha Rajasingham, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2012
Reconsidering cryptococcal antigen screening in the U.S. among persons with CD4 <100 cells/mcLRadha Rajasingham, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2020
Reply to NevesMelanie R Nicol, David R Boulware, Radha Rajasingham
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2012
Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV careRadha Rajasingham, David B Meya, David R Boulware
JAMA Network Open|January 21, 2026
Is It Time to Use Single-Dose Amphotericin B for HIV-Related Cryptococcal Meningitis?Nathan C Bahr, Radha Rajasingham, David R Boulware
Medicine|August 5, 2018
A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in UgandaSarah M Lofgren, Elizabeth Nalintya, David B Meya, et al.
Plos Medicine|October 12, 2012
Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysisRadha Rajasingham, Melissa A Rolfes, Kate E Birkenkamp, et al.
Emerging Infectious Diseases|March 25, 2014
Nosocomial drug-resistant bacteremia in 2 cohorts with cryptococcal meningitis, AfricaRadha Rajasingham, Darlisha Williams, David B Meya, et al.
Pageof 44